| 000 | 01727nam a2200325 4500 | ||
|---|---|---|---|
| 001 | ESSALUD | ||
| 005 | 20260817150548.0 | ||
| 007 | ta | ||
| 008 | t pe ||||| |||| 00| 0 spa d | ||
| 040 | _aBMG | ||
| 041 | _aeng | ||
| 100 |
_aKavanagh, Matthew M. _eAutor _954086 |
||
| 245 | _aThe Inequality–Pandemic Cycle — Rethinking Preparedness | ||
| 300 | _apáginas: 521-524 | ||
| 520 | _aWe are in a new era of pandemics. Over past millennia, millions of people died from infectious diseases, with few tools for stopping deadly pathogens. Today, we have science that previous generations would have considered miraculous — Nobel Prize–winning vaccines, precision antiretrovirals, genomic surveillance systems that can sequence a new pathogen within hours. Yet major outbreaks have become more frequent: Ebola, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), mpox, and more. The largest outbreaks have killed tens of millions of people — at least 44 million have died of AIDS, and 15 million to 18 million died during Covid-19’s first 2 years. | ||
| 650 |
_aCAMBIO CLIMÁTICO _9544 |
||
| 650 |
_aCORONAVIRUS _939659 |
||
| 650 |
_aSALUD GLOBAL _910472 |
||
| 650 |
_aVIH/SIDA _953790 |
||
| 650 |
_aENFERMEDADES INFECCIOSAS GENERALES _954087 |
||
| 650 |
_aINFLUENZA _954088 |
||
| 650 |
_aVACUNAS _98158 |
||
| 650 |
_aINFECCIONES VIRALES _953766 |
||
| 700 |
_aStiglitz, Joseph E. _954089 |
||
| 700 |
_aGeingos, Monica _954090 |
||
| 700 |
_aByanyima, Winnie _954091 |
||
| 700 |
_aMarmot, Michael G. _954092 |
||
| 773 | 0 |
_022717 _922644 _dMassachusetts NEJM Group _oNEJM009 _tThe New England Journal of Medicine _wESSALUD _x0028-4793 |
|
| 942 |
_cARTICULOS _e2026-08-17 _zSQB |
||
| 999 |
_c22823 _d22823 |
||